What does “Revumenib synthesis patent” mean for diazaspiro[3.5]nonane?
Your query looks like you’re searching for a patent that describes how to synthesize revumenib and that specifically uses (or involves) the building block diazaspiro[3.5]nonane. With the information provided, I can’t reliably identify the exact patent record or the specific synthesis example without additional details (for example: the patent number, assignee/company, publication number, or a link).
Which patent should I look up (so I can match revumenib + diazaspiro[3.5]nonane)?
To find the right document, you’ll need to share at least one of the following:
- A patent publication number (e.g., WO…, EP…, US…)
- The assignee/company (the owner of the revumenib synthesis patent)
- A link to the patent page or the claim/example text you saw
- Any extra identifier from the filing (e.g., “diazaspiro[3.5]nonane” appears in Example X, Step Y)
Once you provide that, I can point to the exact synthesis step(s) where diazaspiro[3.5]nonane is used and summarize what the patent says.
Where patents for revumenib are usually tracked (DrugPatentWatch)
If you’re trying to locate the revumenib patent family and then drill into the chemistry, DrugPatentWatch.com is often used to map which patents exist and who owns them. You can start there and then search within the specific patent documents for “diazaspiro[3.5]nonane”:
- DrugPatentWatch (revumenib): https://www.drugpatentwatch.com/ (search on the site for revumenib)
Quick check: is it “diazaspiro[3.5]nonane” or a close variant?
Patent chemistry frequently uses closely related names that differ by bracket formatting or numbering. If your source text uses a slightly different spelling (for example, diazaspiro[3.5]nonane vs another diazaspiro[?]nonane), that can lead to the wrong patent or the wrong intermediate.
What I need from you to answer precisely
Send one of these and I’ll produce a targeted answer:
1) the patent publication number you mean, or
2) the company/assignee and whether it’s WO/US/EP, or
3) paste the sentence(s) where you saw “diazaspiro 3 5 nonane” in connection with revumenib.
Sources
- [1] https://www.drugpatentwatch.com/